CTS Corporation Declares a Dividend and Share Repurchase Program
Rhea-AI Summary
CTS Corporation (NYSE: CTS) declared a $0.04 per share cash dividend payable on Jan 23, 2026 to shareholders of record on Dec 26, 2025. The board also authorized a new $100 million share repurchase program to replace the February 2024 plan.
The repurchase program has no set expiration date and permits buys in the open market or via privately negotiated transactions; timing and amounts will depend on market conditions and other factors.
Positive
- Declared cash dividend of $0.04 per share
- Authorized $100 million share repurchase program
- Repurchase program has no expiration date
Negative
- Dividend amount is modest relative to large-cap payouts
- Repurchases subject to market conditions; timing uncertain
News Market Reaction 1 Alert
On the day this news was published, CTS declined 0.71%, reflecting a mild negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
LISLE, Ill., Nov. 07, 2025 (GLOBE NEWSWIRE) -- The Board of Directors of CTS Corporation (NYSE: CTS) has declared a cash dividend of
CTS Corporation also announced a new share repurchase program authorizing the company to buy back up to
This program replaces the prior share repurchase program that was approved in February 2024. The program has no set expiration date and allows for repurchases to be made from time to time in the open market or through privately negotiated transactions. The timing and actual amount of shares repurchased depend on various factors, including market conditions.
About CTS
CTS Corporation (NYSE: CTS) is a leading designer and manufacturer of products that Sense, Connect and Move. CTS manufactures sensors, actuators and electronic components in North America, Europe and Asia, and provides engineered products to customers in the aerospace/defense, industrial, medical and transportation markets. For more information, visit www.ctscorp.com.
Contact
Ashish Agrawal
Vice President and Chief Financial Officer
CTS Corporation
4925 Indiana Avenue
Lisle, IL 60532 USA
+1 (630) 577-8800
ashish.agrawal@ctscorp.com